Literature DB >> 1167868

The thyrotropin in hydatidiform moles is human chorionic gonadotropin.

J G Kenimer, J M Hershman, H P Higgins.   

Abstract

Thyrotropic activity (TSH), measured by the McKenzie mouse bioassay, has been correlated with human chorionic gonadotropin (hCG) activity, measured by radioimmunoassay, in serum and tissue samples from 11 patients with hydatidiform mole and in partially and highly purified preparations of urinary hCG. Serum samples, taken at various times before and after removal of the moles, gave a ratio of 0.42 plus or minus 0.24 muU TSH/U hCG (mean plus or minus SD) (N)=43). In all cases where hCG activity fell below 150-175 U/ml (n=49), thyroid stimulating activity was undetectable (smaller than 40 muU/ml). We extracted lyophylized molar tissue by a modification of the Bates alcohol-saline method and purified the resultant extract by a combination of gel chromatography, affinity chromatography using Concanavalin A coupled to Sepharose, and isoelectrofocusing. Following extraction, an approximately 20-fold purification was achieved without significant alteration of the ratio of the two activities. Using results from all phases of purification the ratio of muU TSH/U hCG was 0.51 plus or minus 0.35(n = 23). Both activities were in the same position on disc gel electrophoresis. Activity ratios were less constant when partially purified preparations of urinary hCG were assayed for both thyrotropic and hCG activities. The presence of an hCG immunoreactive species, presumably hCG-beta subunit, which contains no thyrotropic activity but has an approximately 10-fold greater activity on a weight basis than intact hCG, may be a partial explanation for this observation. Isoelectrofocusing of a urinary hCG preparation showed that all hCG immunoreactive species with pl's between 3. 5 and 5.0 contained thyrotropic activity in proportion to their hCG content. Seven highly purified hCG preparations had thyrotropic activity with a ratio of 0.48 plus or minus 0.18 muU TSH/U hCG. These results indicate that hCG has intrinsic thyrotropic activity. On a molecular basis it is calculated that hCG contains approximately 1/4000 the thyrotropic activity of human pituitary TSH. In conditions of grossly elevated serum hCG levels, such as hydatidiform mole, this thyrotropic activity can be sufficient to produce hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167868     DOI: 10.1210/jcem-40-3-482

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Editorial: Hyperthyroidism of hydatidiform mole.

Authors: 
Journal:  Br Med J       Date:  1976-01-24

2.  Endocrinology and treatment of trophoblastic tumours.

Authors:  K D Bagshawe
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

3.  Secretion of pituitary-like peptides by the human placenta.

Authors:  L H Rees
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1976

4.  Thyroid disease in pregnancy.

Authors:  P E Belchetz
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-31

Review 5.  Management of endocrine disorders in pregnancy Part I--thyroid and parathyroid disease.

Authors:  Z M van der Spuy; H S Jacobs
Journal:  Postgrad Med J       Date:  1984-04       Impact factor: 2.401

Review 6.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

Review 7.  Thyroid stimulation by placental factors.

Authors:  K Mann; R Hoermann
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

8.  Hypothyroidism associated with anti-human chorionic gonadotropin antibodies secondarily produced by gonadotropin therapy in a case of idiopathic hypothalamic hypogonadism.

Authors:  T Ogura; Y Mimura; F Otsuka; M Kishida; K Yokota; J Suzuki; A Nagai; S Hirakawa; H Makino; K Tobe
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

9.  Anesthetic management of a patient with hyperthyroidism due to hydatidiform mole.

Authors:  Shigekiyo Matsumoto; Chihiro Shingu; Seigo Hidaka; Koji Goto; Satoshi Hagiwara; Hideo Iwasaka; Takayuki Noguchi
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

10.  Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo.

Authors:  R Hoermann; P M Schumm-Draeger; K Rehbach; K Mann
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.